Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

227.99
Delayed Data
As of Aug 16
 -3.15 / -1.36%
Today’s Change
184.50
Today|||52-Week Range
256.80
+8.56%
Year-to-Date
AGN Regular Dividend: AGN began trading ex-dividend on 08/16/17. A $0.70 dividend will be paid to shareholders of record as of 08/18/17.
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Pressing AGN Again
Aug 16 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
Teva Is Cheap, Not Dead
Aug 16 / TheStreet.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
Mid Afternoon Musings
Aug 15 / TheStreet.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content
Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices
Aug 16 / TheStreet.com - Paid Partner Content
Jim Cramer Says Allergan Shares Are 'Just Too Cheap'
Aug 11 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close231.14
Today’s open231.12
Day’s range227.07 - 231.62
Volume3,546,750
Average volume (3 months)2,156,860
Market cap$77.3B
Dividend yield1.23%
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.11%
Earnings growth (next 5 years)+15.23%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.12+0.41%
ABTAbbott Laboratories+0.99+2.03%
NVONovo Nordisk+0.90+1.98%
LLYEli Lilly and Co-1.02-1.25%
Data as of 08/16/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.17
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts